Lucheng Zhu

967 total citations
54 papers, 713 citations indexed

About

Lucheng Zhu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Lucheng Zhu has authored 54 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Lucheng Zhu's work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Lucheng Zhu is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Lucheng Zhu collaborates with scholars based in China and United States. Lucheng Zhu's co-authors include Shirong Zhang, Shenglin Ma, Kan Wu, Yasi Xu, Bing Xia, Shenglin Ma, Changlin Zou, Hong Jiang, Wen-Hua Luo and Hongfang Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Lucheng Zhu

48 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucheng Zhu China 16 277 261 229 194 87 54 713
Andrew P. Sciallis United States 15 225 0.8× 162 0.6× 254 1.1× 172 0.9× 47 0.5× 39 770
Maria Rosa Cappelletti Italy 13 213 0.8× 251 1.0× 312 1.4× 239 1.2× 57 0.7× 32 635
Joshua Li Hong Kong 16 224 0.8× 163 0.6× 281 1.2× 176 0.9× 54 0.6× 97 765
Kamlesh K. Yadav United States 14 412 1.5× 322 1.2× 156 0.7× 305 1.6× 96 1.1× 30 895
Samanta Sarti Italy 17 205 0.7× 193 0.7× 490 2.1× 209 1.1× 88 1.0× 46 803
Francesca Romana Tofanetti Italy 14 375 1.4× 386 1.5× 394 1.7× 214 1.1× 79 0.9× 32 781
Myriam Kossaï France 10 277 1.0× 173 0.7× 279 1.2× 258 1.3× 42 0.5× 36 768
Fangmeng Fu China 15 293 1.1× 130 0.5× 211 0.9× 286 1.5× 77 0.9× 66 744
Yanqing Wang China 18 249 0.9× 353 1.4× 291 1.3× 195 1.0× 79 0.9× 30 740
Ran Xie United States 12 295 1.1× 185 0.7× 221 1.0× 141 0.7× 85 1.0× 32 676

Countries citing papers authored by Lucheng Zhu

Since Specialization
Citations

This map shows the geographic impact of Lucheng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucheng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucheng Zhu more than expected).

Fields of papers citing papers by Lucheng Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucheng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucheng Zhu. The network helps show where Lucheng Zhu may publish in the future.

Co-authorship network of co-authors of Lucheng Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Lucheng Zhu. A scholar is included among the top collaborators of Lucheng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucheng Zhu. Lucheng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Linling, Yasi Xu, Yanyan Zhao, Bing Xia, & Lucheng Zhu. (2025). Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients. Cancer Immunology Immunotherapy. 74(11). 334–334.
3.
Zhu, Lucheng, Kan Wu, Minna Zhang, et al.. (2024). Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation. Discover Oncology. 15(1). 509–509. 2 indexed citations
4.
Wang, Zhiyue, Jian Wang, Zhe Geng, et al.. (2023). RACS2: a framework of a remote autonomous control system for telescope observation and its application. Frontiers in Astronomy and Space Sciences. 10. 4 indexed citations
6.
Zhu, Lucheng, Shenglin Ma, & Bing Xia. (2022). Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report. Frontiers in Oncology. 12. 1009076–1009076. 7 indexed citations
7.
Geng, Zhe, Zhiyue Wang, Qian Zhang, et al.. (2022). Design of a remote control system for a camera system based on EPICS and web technology. 70–70.
8.
Wang, Yuqing, Jie Huang, Qiong Wu, et al.. (2021). Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha. Frontiers in Oncology. 11. 668798–668798. 7 indexed citations
9.
Zhao, Lei, Song Gu, Yi Tang, et al.. (2021). Deep learning-based automatic delineation of the hippocampus by MRI: geometric and dosimetric evaluation. Radiation Oncology. 16(1). 12–12. 14 indexed citations
10.
11.
Zhu, Lucheng, Yajun Wu, Pengyuan Liu, et al.. (2020). Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study. BMC Cancer. 20(1). 827–827. 10 indexed citations
12.
Zhu, Lucheng, Zhibing Wu, & Shenglin Ma. (2019). Chemotherapeutic hyperthermic intraperitoneal perfusion following radical D2 resection in the treatment of advanced gastric cancer. Annals of Oncology. 30. iv5–iv6. 1 indexed citations
13.
Wu, Kan, Xiao Xu, Lucheng Zhu, et al.. (2018). Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapy. Journal of Thoracic Disease. 10(12). 6531–6539. 13 indexed citations
14.
Xu, Yasi, Dan Su, Lucheng Zhu, et al.. (2018). S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1. Journal of Ovarian Research. 11(1). 39–39. 23 indexed citations
15.
Zhao, Yanyan, Shirong Zhang, Zhibing Wu, et al.. (2017). P2.05-029 Microwave Thermal Therapy Enhances Radiosensitivity of Highly Invasive Human Non-Small Cell Lung Cancer H460 Cells via Inhibiting DNA Repair. Journal of Thoracic Oncology. 12(1). S1048–S1048. 2 indexed citations
16.
Xu, Yasi, Shirong Zhang, Bing Xia, Lucheng Zhu, & Shenglin Ma. (2017). P2.05-005 Mechanism of Radiotherapy in Reduction/Delay of T790M-Mediated EGFR TKI Resistance. Journal of Thoracic Oncology. 12(1). S1033–S1033. 1 indexed citations
18.
Su, Meng, et al.. (2014). Primary anorectal malignant melanoma treated with neoadjuvant chemoradiotherapy and sphincter-sparing surgery: A case report. Oncology Letters. 7(5). 1605–1607. 5 indexed citations
19.
Zhu, Lucheng, Wen-Hua Luo, Meng Su, et al.. (2013). A Model to Discriminate Malignant from Benign Thyroid Nodules Using Artificial Neural Network. PLoS ONE. 8(12). e82211–e82211. 39 indexed citations
20.
Zhu, Lucheng, Wen-Hua Luo, Meng Su, et al.. (2013). Comparison between artificial neural network and Cox regression model in predicting the survival rate of gastric cancer patients. Biomedical Reports. 1(5). 757–760. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026